Farris Maryanne Maunsell - Jun 5, 2025 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role
VP, Chief Accounting Officer
Signature
/s/ Thomas V. Powers, attorney-in-fact for Ms. Farris
Stock symbol
HAE
Transactions as of
Jun 5, 2025
Transactions value $
$0
Form type
4
Date filed
6/9/2025, 04:49 PM
Previous filing
May 20, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Maunsell Farris Maryanne VP, Chief Accounting Officer 125 SUMMER STREET, BOSTON /s/ Thomas V. Powers, attorney-in-fact for Ms. Farris 2025-06-09 0001950052

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HAE Common Stock Award +2.66K +146.59% 4.48K Jun 5, 2025 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. Two-thirds of the RSUs vest in two equal annual installments beginning on the first anniversary of the date of grant and one-third of the RSUs vests based on the Issuer's common stock price at the end of a two-year performance period.
F2 Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
F3 This number includes unvested RSUs previously reported.